clinical trial · NCT05345509
A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003.
Inventage Lab., Inc.·phase2·active not recruiting·n = 62
Alzheimer DiseaseAricept TabletIVL3003IVL3003
brief summary
A Clinical Trial to Assess Pharmacokinetic Profiles and Safety of IVL3003
started
Apr 1, 2023
primary completion
Nov 13, 2025
completion
Nov 13, 2025
last updated
Dec 19, 2024
detailed description
A Phase 1, Randomized, Open-Label, Exploratory, Sequential, Pharmacokinetic Single Ascending Dose Study of IVL3003 Versus Multiple Doses of Aricept (Donepezil) Tablets in Healthy Subjects
official title
A Phase 1, Randomized, Open-Label, Exploratory, Sequential, Pharmacokinetic Single Ascending Dose Study of IVL3003 Versus Multiple Doses of Aricept (Donepezil) Tablets in Healthy Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol